These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1382930)

  • 1. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report.
    Rogawski MA
    Drugs; 1992 Sep; 44(3):279-92. PubMed ID: 1382930
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
    Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
    J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of the associated glycine recognition site by competitive N-methyl-D-aspartate receptor antagonists.
    Monahan JB; Biesterfeldt JP; Hood WF; Compton RP; Cordi AA; Vazquez MI; Lanthorn TH; Wood PL
    Mol Pharmacol; 1990 Jun; 37(6):780-4. PubMed ID: 2163012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitatory amino acid antagonists and epilepsy.
    Chapman AG; Meldrum BS
    Biochem Soc Trans; 1993 Feb; 21(1):106-10. PubMed ID: 8449271
    [No Abstract]   [Full Text] [Related]  

  • 7. NMDA antagonists: their role in neuroprotection.
    Small DL; Buchan AM
    Int Rev Neurobiol; 1997; 40():137-71. PubMed ID: 8989620
    [No Abstract]   [Full Text] [Related]  

  • 8. Noncompetitive NMDA antagonists: a novel synthesis of 1-phenyltetrahydro-3-benzazepines.
    Wünsch B; Nerdinger S; Bauschke G; Höfner G
    Arch Pharm (Weinheim); 1997 Jul; 330(7):211-4. PubMed ID: 9311300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The teratogenicity of N-methyl-D-aspartate (NMDA) receptor antagonists.
    Polifka JE; Shepard TH
    Pediatr Res; 1998 Sep; 44(3):415; author reply 416-7. PubMed ID: 9727723
    [No Abstract]   [Full Text] [Related]  

  • 10. The teratogenicity of N-methyl-D-aspartate (NMDA) receptor antagonists.
    Brent RL
    Pediatr Res; 1998 Sep; 44(3):415-7. PubMed ID: 9727724
    [No Abstract]   [Full Text] [Related]  

  • 11. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats.
    Sun W; Wessinger WD
    Life Sci; 2004 Aug; 75(12):1405-15. PubMed ID: 15240177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
    Montastruc JL; Fabre N; Rascol O; Senard JM; Blin O
    Mov Disord; 1994 Mar; 9(2):242-3. PubMed ID: 8196695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Roles of glutamate receptor in c-fos gene expression and epilepsy susceptibility in rats].
    Shan WS; Wu XR; Liang WL
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):481-2, 518. PubMed ID: 7994657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutamate in epilepsy and other CNS disorders.
    Meldrum BS
    Neurology; 1994 Nov; 44(11 Suppl 8):S14-23. PubMed ID: 7970002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function.
    Iorio KR; Reinlib L; Tabakoff B; Hoffman PL
    Mol Pharmacol; 1992 Jun; 41(6):1142-8. PubMed ID: 1535416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of N-methyl-D-aspartate receptors in the release of adrenocorticotropin by dynorphin A1-13.
    Szeto HH; Soong Y; Wu D
    Neuroendocrinology; 1999 Jan; 69(1):28-33. PubMed ID: 9892848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model.
    McDonald JW; Johnston MV
    Synapse; 1990; 6(2):179-88. PubMed ID: 1978420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels.
    Kuo CC; Lin BJ; Chang HR; Hsieh CP
    Mol Pharmacol; 2004 Feb; 65(2):370-80. PubMed ID: 14742679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.